COVID-19 Vaccine Used in Much of the World No Match for Omicron Variant
Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce…
Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce…
Study sheds light on COVID virus transmissibility, resistance to host immunity. The virus that causes COVID-19 has adopted some stealth moves to stay alive and…
Daniel Becker, an assistant professor of biology in the University of Oklahoma’s Dodge Family College of Arts and Sciences, has been leading a proactive modeling…
Nano-bubble evACE2 fights new variants as well as or better than original strain of virus. Drug can be delivered as nasal spray Acts as decoy…
A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses could offer a sufficient level…
One viral protein may provide clues for preventing pneumonia, which is brought on by the body’s heightened inflammatory response to respiratory viruses like the COVID-19…
A new analysis of data from U.S. military recruits suggests multiple sclerosis (MS) – a disease considered of unknown etiology – is a complication of…
UC San Diego develops computer model to aid understanding of how viruses travel through the air. In May 2021, the Centers for Disease Control officially…
Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection…
An international research team led by scientists at Georgetown University have demonstrated the power of artificial intelligence to predict which viruses could infect humans —…
Carolina researchers design rapid sensing COVID-19 test to meet the challenge of tracking variants and global disease containment. Even those tracking each new discovery about…
A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T…
In order to fight the COVID-19 pandemic in the long term, it is crucial to understand why one SARS-CoV-2 variant prevails over another. An international…
The new drug, Paxlovid, significantly reduced hospitalization and death in adult patients and is authorized for emergency use in the United States. On December 22,…
Using a new robotic platform, researchers can simultaneously track hundreds of microbial populations as they evolve new proteins or other molecules. Natural evolution is a…
It is widely understood that antibodies neutralize viruses by latching onto their surfaces and blocking them from infecting host cells. But new research reveals that…
Austrian researchers developed detailed epidemiological model for the spread of the coronavirus in nursing homes. Researchers from TU Graz and Complexity Science Hub (CSH) Vienna…
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to…